Isolation Bio, Inc.
PrivateLast Round
Series B
Nov 25, 2020
Total Funding Raised
$37.14M
Company Overview
Isolation Bio, Inc. is a biotechnology company that provides automated, high-throughput microbial cultivation and isolation platforms to accelerate microbiome research and product development across human, animal, agricultural, and environmental health sectors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Isolation Bio, Inc. Comparables
Compare Isolation Bio, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Danaher | 73% | |
| Singer Instruments | 73% | |
| BICO Group | 72% |
Isolation Bio, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 25, 2020 | ||||
| Series A | Jul 24, 2018 | ||||
| Seed | Apr 26, 2017 | ||||
| Follow-on Offering | Jan 23, 2017 | ||||
| Seed | Jan 20, 2016 |
Isolation Bio, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Formation 8 | Follow-on Offering |
| Northpond Ventures | Series B, Series A |
| Paladin Capital Group | Follow-on Offering |
| Washington State Department of Agriculture | Grant |
| Mission Bay Capital | Seed |
| Vital Venture Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 14, 2025
Monthly visitors grew 146% MoM, reaching 1.4K.
- Nov 25, 2020
$15M round led by Northpond Ventures
Isolation Bio, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Isolation Bio, Inc.'s valuation, stock price, and market status.
Is Isolation Bio, Inc. a public or private company?
Isolation Bio, Inc. is a private company.
What is the current stock price of Isolation Bio, Inc.?
Isolation Bio, Inc. is a private company, so its shares have no public market price. Caplight tracks Isolation Bio, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Isolation Bio, Inc. worth (valuation)?
Valuation information for Isolation Bio, Inc. is not publicly available.
Can I buy Isolation Bio, Inc. stock?
Isolation Bio, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Isolation Bio, Inc.'s last funding round?
Isolation Bio, Inc.'s most recent funding round was Series B on November 25, 2020.
Who are the main investors in Isolation Bio, Inc.?
Key investors in Isolation Bio, Inc. include Northpond Ventures, Washington State Department of Agriculture.
Will Isolation Bio, Inc. IPO soon?
No public IPO plans have been announced for Isolation Bio, Inc..
How can I track Isolation Bio, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Isolation Bio, Inc.'s shares on secondary markets.